MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 98 filers reported holding MAXCYTE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,092,555 | -31.9% | 1,952,742 | +0.2% | 0.00% | -33.3% |
| Q2 2023 | $8,947,631 | -8.2% | 1,949,375 | -1.0% | 0.00% | 0.0% |
| Q1 2023 | $9,742,793 | -9.3% | 1,968,241 | +0.0% | 0.00% | -25.0% |
| Q4 2022 | $10,745,602 | -35.0% | 1,968,059 | -22.6% | 0.00% | -33.3% |
| Q3 2022 | $16,526,000 | +47.6% | 2,542,463 | +7.4% | 0.01% | +50.0% |
| Q2 2022 | $11,200,000 | -14.4% | 2,367,838 | +26.5% | 0.00% | 0.0% |
| Q1 2022 | $13,087,000 | -29.5% | 1,872,197 | +2.8% | 0.00% | -20.0% |
| Q4 2021 | $18,554,000 | -2.7% | 1,820,805 | +16.6% | 0.01% | -16.7% |
| Q3 2021 | $19,060,000 | – | 1,561,056 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH RUN CAPITAL, LP | 480,900 | $3,361,000 | 4.94% |
| Casdin Capital, LLC | 13,971,334 | $97,660,000 | 4.38% |
| Vitruvian Partners LLP | 4,385,670 | $30,656,000 | 3.25% |
| RIVER GLOBAL INVESTORS LLP | 2,100,000 | $14,849,000 | 1.95% |
| APIS CAPITAL ADVISORS, LLC | 180,000 | $1,258,000 | 1.52% |
| Pier Capital, LLC | 1,017,753 | $7,114,000 | 0.91% |
| First Light Asset Management, LLC | 1,321,406 | $9,237,000 | 0.82% |
| Montanaro Asset Management Ltd | 929,000 | $6,557,000 | 0.81% |
| Nicholas Investment Partners, LP | 776,963 | $5,431,000 | 0.39% |
| Bleichroeder LP | 250,000 | $1,764,000 | 0.31% |